Literature DB >> 8101553

Application of biotyping and DNA typing of Candida albicans to the epidemiology of recurrent vulvovaginal candidiasis.

S Mercure1, S Poirier, G Lemay, P Auger, S Montplaisir, L de Repentigny.   

Abstract

One-hundred and five Candida albicans isolates from various anatomic sites of 28 patients, obtained at the onset of two consecutive episodes of well-documented recurrent vulvovaginitis, were typed by methods relying on physiologic or genomic markers. The isolates represented a wide variety of types, and neither a single biotype nor genotype was associated with recurrent vaginitis or a particular body site. Patients generally carried similar strains at various anatomic sites that persisted over time. Genomic methods indicated an 86% rate of relapse, which suggested that most recurrent vaginal infections are of endogenous origin. A similar evaluation with biotyping methods was inconclusive because of a lack of reproducibility, resulting from clonal variation or switching, and difficulties in establishing the number of phenotypic tests necessary to distinguish between identical and different strains. Therefore, Southern hybridization was considered the ideal reference method to study the epidemiology of C. albicans infections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101553     DOI: 10.1093/infdis/168.2.502

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

Review 1.  The ins and outs of DNA fingerprinting the infectious fungi.

Authors:  D R Soll
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

2.  An investigation into the pathogenesis of vulvo-vaginal candidosis.

Authors:  S S El-Din; M T Reynolds; H R Ashbee; R C Barton; E G Evans
Journal:  Sex Transm Infect       Date:  2001-06       Impact factor: 3.519

3.  Molecular probe for typing strains of Candida albicans.

Authors:  P Postlethwait; B Bell; W T Oberle; P Sundstrom
Journal:  J Clin Microbiol       Date:  1996-02       Impact factor: 5.948

4.  Candida albicans serotype analysis by flow cytometry.

Authors:  S Mercure; S Sénéchal; P Auger; G Lemay; S Montplaisir
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

5.  Change in colony morphology of Candida lusitaniae in association with development of amphotericin B resistance.

Authors:  Nancy B McClenny; Haihua Fei; Ellen J Baron; Ana C Gales; Allison Houston; Richard J Hollis; Michael A Pfaller
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  High-frequency, in vitro reversible switching of Candida lusitaniae clinical isolates from amphotericin B susceptibility to resistance.

Authors:  S A Yoon; J A Vazquez; P E Steffan; J D Sobel; R A Akins
Journal:  Antimicrob Agents Chemother       Date:  1999-04       Impact factor: 5.191

7.  Candida albicans strain maintenance, replacement, and microvariation demonstrated by multilocus sequence typing.

Authors:  F C Odds; A D Davidson; M D Jacobsen; A Tavanti; J A Whyte; C C Kibbler; D H Ellis; M C J Maiden; D J Shaw; N A R Gow
Journal:  J Clin Microbiol       Date:  2006-10       Impact factor: 5.948

8.  Most frequent scenario for recurrent Candida vaginitis is strain maintenance with "substrain shuffling": demonstration by sequential DNA fingerprinting with probes Ca3, C1, and CARE2.

Authors:  S R Lockhart; B D Reed; C L Pierson; D R Soll
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Investigation of Candida albicans transmission in a surgical intensive care unit cluster by using genomic DNA typing methods.

Authors:  A Voss; M A Pfaller; R J Hollis; J Rhine-Chalberg; B N Doebbeling
Journal:  J Clin Microbiol       Date:  1995-03       Impact factor: 5.948

10.  Correlation between the presence of a self-splicing intron in the 25S rDNA of C.albicans and strains susceptibility to 5-fluorocytosine.

Authors:  S Mercure; S Montplaisir; G Lemay
Journal:  Nucleic Acids Res       Date:  1993-12-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.